Sagimet Biosciences Inc (SGMT)
4.97
-0.10
(-1.97%)
USD |
NASDAQ |
Dec 20, 16:00
5.22
+0.25
(+5.03%)
Pre-Market: 20:00
Sagimet Biosciences Enterprise Value: 7.525M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Madrigal Pharmaceuticals Inc | 5.852B |
| Y-mAbs Therapeutics Inc | 302.73M |
| CEL-SCI Corp | 46.19M |
| AIM ImmunoTech Inc | 7.634M |
| IGC Pharma Inc | 27.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.62M |
| Total Expenses (Quarterly) | 16.90M |
| EPS Diluted (Quarterly) | -0.45 |
| Earnings Yield | -25.88% |